Delivery Order SPE2DB20D3505-SPE2DB25FU1A6

Award Date 3/3/25
Potential Completion Date 3/4/25
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for a ceiling value of $3,111.61. The contract has a completion date of July 16, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
The federal contract award is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,516.20 and is a Delivery Order with a Firm Fixed Price pricing type. The ultimate completion date is December 3, 2024. This contract award is not designated with a set-aside. Amerisourcebergen...
This federal contract award is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award has a ceiling value of $3,583.59 and is a Firm Fixed Price Delivery Order contract with an ultimate completion date of August 1, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and...
This federal contract award is for the delivery of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,702.34 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, through the DLA's Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The IDC serves as a primary vehicle for providing a range of pharmaceutical products and medical supplies to support military...
The federal contract award is for the delivery of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,388.15 and an ultimate completion date of November 3, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type, awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract award is part of a...
This federal contract award is for the pharmaceutical product BRIVIACT 100 MG TABLET 60S, with a ceiling value of $1,009.83. The award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of November 21, 2024. The contract is not designated as a set-aside. Amerisourcebergen...
This federal contract award is for the delivery of BRIVIACT 75 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,161.80 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 17, 2024 with a completion date of October 18, 2024. The contract is a Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of BRIVIACT 100 MG TABLET 60S. The $1,126.24 firm fixed price contract has an ultimate completion date of October 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award is for the delivery of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,603.25 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, through an Indefinite Delivery Contract valued at $999,999,999 with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award is for the delivery of BRIVIACT 75 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,113.20 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 17, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB25FU1A6
    Delivery Order

This federal contract award is for the delivery of BRIVIACT 100 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $3,050.21. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/2/25, 9:43 AM